Celldex Therapeutics, Inc.

BOOTHBAY FUND MANAGEMENT, LLC CLDX

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/15/2026

Shares

134,945

Value ($000)

4,280

Weight

0.1%

2020 Q2 - 2026 Q1 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/15/2026	4,280	0.1%	134,945	3/31/2026
2023 Q1	5/15/2023	704	0.0%	19,576	3/31/2023
2022 Q4	2/14/2023	1,394	0.0%	31,273	12/31/2022
2022 Q3	11/14/2022	1,043	0.0%	37,118	9/30/2022
2022 Q2	8/15/2022	1,673	0.0%	62,065	6/30/2022
2022 Q1	5/16/2022	2,114	0.0%	62,065	3/31/2022
2021 Q4	2/14/2022	1,756	0.0%	45,450	12/31/2021
2021 Q3	11/15/2021	1,426	0.0%	26,409	9/30/2021
2021 Q2	8/17/2021	1,750	0.1%	52,338	6/30/2021
2021 Q1	5/17/2021	1,528	0.1%	74,199	3/31/2021
2020 Q4	2/12/2021	3,148	0.1%	179,670	12/31/2020
2020 Q3	11/16/2020	2,760	0.2%	186,117	9/30/2020
2020 Q2	8/14/2020	2,715	0.2%	208,836	6/30/2020